Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review
Identifieur interne : 002519 ( Main/Exploration ); précédent : 002518; suivant : 002520Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review
Auteurs : M. Mar Trujillo-Martin [Espagne] ; Pedro Serrano-Aguilar [Espagne] ; Fernando Monton-Alvarez [Espagne] ; Romen Carrillo-Fumero [Espagne]Source :
- Movement disorders [ 0885-3185 ] ; 2009.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The aim of this study was to determine the effectiveness and safety of available treatment alternatives for degenerative ataxias (DA). We systematically reviewed studies that assess pharmacological, rehabilitative, or psychological treatments in patients with DA. Studies were included if they fulfilled prespecified criteria. All included clinical trials were scored for methodological quality. Main outcome measures were clinical status of neurological disorder, adverse events, and patient-based factors. Twenty-five studies were included. Most studies were of small sample sizes, wide age variations, and low scientific validity. Only one study gave information on physical rehabilitation and none on psychological therapy. The remaining 24 studies reported on the effects of different pharmacological treatments. Outcomes such as functional capacity and psychological functioning of patients were evaluated by few studies. Some evidence supports that 5-hydroxy-tryptophan is more effective than placebo improving neurological symptoms in patients with Friedreich ataxia (FA), olivopontocerebellar atrophy, or cerebellar atrophy. Idebenone is more effective than placebo for halting and reversing the hypertrophic cardiomyopathy associated with FA, but it seems unable to improve neurological semiology. Limited evidence for other therapies was found. No relevant side effects for drugs that shown some degree of effectiveness were reported. Availability of quality studies to evaluate the safety and efficacy of treatments for most DA is scarce. No valid information on the actual value of physical rehabilitation and psychological support as treatments for DA is available. Further investigations with improved trial designs are necessary. © 2009 Movement Disorder Society.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000E55
- to stream PascalFrancis, to step Curation: 001E64
- to stream PascalFrancis, to step Checkpoint: 000E94
- to stream Main, to step Merge: 002F91
- to stream Main, to step Curation: 002519
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review</title><author><name sortKey="Trujillo Martin, M Mar" sort="Trujillo Martin, M Mar" uniqKey="Trujillo Martin M" first="M. Mar" last="Trujillo-Martin">M. Mar Trujillo-Martin</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Canary Islands Research and Health Foundation (Fundación Canaria de Investigación y Salud-FUNCIS), Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation></author><author><name sortKey="Serrano Aguilar, Pedro" sort="Serrano Aguilar, Pedro" uniqKey="Serrano Aguilar P" first="Pedro" last="Serrano-Aguilar">Pedro Serrano-Aguilar</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Planning and Evaluation Unit, Canary Islands Health Authority, Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>2 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CIBER Epidemiología y Salud Pública (CIBERESP)</s1><s3>ESP</s3><sZ>2 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>CIBER Epidemiología y Salud Pública (CIBERESP)</wicri:noRegion></affiliation></author><author><name sortKey="Monton Alvarez, Fernando" sort="Monton Alvarez, Fernando" uniqKey="Monton Alvarez F" first="Fernando" last="Monton-Alvarez">Fernando Monton-Alvarez</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, University Hospital of N<sup>a</sup>S<sup>a</sup>de la Candelaria, Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>3 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation></author><author><name sortKey="Carrillo Fumero, Romen" sort="Carrillo Fumero, Romen" uniqKey="Carrillo Fumero R" first="Romen" last="Carrillo-Fumero">Romen Carrillo-Fumero</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Canary Islands Research and Health Foundation (Fundación Canaria de Investigación y Salud-FUNCIS), Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">09-0301981</idno><date when="2009">2009</date><idno type="stanalyst">PASCAL 09-0301981 INIST</idno><idno type="RBID">Pascal:09-0301981</idno><idno type="wicri:Area/PascalFrancis/Corpus">000E55</idno><idno type="wicri:Area/PascalFrancis/Curation">001E64</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000E94</idno><idno type="wicri:doubleKey">0885-3185:2009:Trujillo Martin M:effectiveness:and:safety</idno><idno type="wicri:Area/Main/Merge">002F91</idno><idno type="wicri:Area/Main/Curation">002519</idno><idno type="wicri:Area/Main/Exploration">002519</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review</title><author><name sortKey="Trujillo Martin, M Mar" sort="Trujillo Martin, M Mar" uniqKey="Trujillo Martin M" first="M. Mar" last="Trujillo-Martin">M. Mar Trujillo-Martin</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Canary Islands Research and Health Foundation (Fundación Canaria de Investigación y Salud-FUNCIS), Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation></author><author><name sortKey="Serrano Aguilar, Pedro" sort="Serrano Aguilar, Pedro" uniqKey="Serrano Aguilar P" first="Pedro" last="Serrano-Aguilar">Pedro Serrano-Aguilar</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Planning and Evaluation Unit, Canary Islands Health Authority, Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>2 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CIBER Epidemiología y Salud Pública (CIBERESP)</s1><s3>ESP</s3><sZ>2 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>CIBER Epidemiología y Salud Pública (CIBERESP)</wicri:noRegion></affiliation></author><author><name sortKey="Monton Alvarez, Fernando" sort="Monton Alvarez, Fernando" uniqKey="Monton Alvarez F" first="Fernando" last="Monton-Alvarez">Fernando Monton-Alvarez</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, University Hospital of N<sup>a</sup>S<sup>a</sup>de la Candelaria, Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>3 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation></author><author><name sortKey="Carrillo Fumero, Romen" sort="Carrillo Fumero, Romen" uniqKey="Carrillo Fumero R" first="Romen" last="Carrillo-Fumero">Romen Carrillo-Fumero</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Canary Islands Research and Health Foundation (Fundación Canaria de Investigación y Salud-FUNCIS), Santa Cruz de Tenerife</s1><s2>Canary Islands</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Espagne</country><wicri:noRegion>Canary Islands</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ataxia</term><term>Nervous system diseases</term><term>Rare disease</term><term>Safety</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Ataxie</term><term>Pathologie du système nerveux</term><term>Sécurité</term><term>Traitement</term><term>Maladie rare</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to determine the effectiveness and safety of available treatment alternatives for degenerative ataxias (DA). We systematically reviewed studies that assess pharmacological, rehabilitative, or psychological treatments in patients with DA. Studies were included if they fulfilled prespecified criteria. All included clinical trials were scored for methodological quality. Main outcome measures were clinical status of neurological disorder, adverse events, and patient-based factors. Twenty-five studies were included. Most studies were of small sample sizes, wide age variations, and low scientific validity. Only one study gave information on physical rehabilitation and none on psychological therapy. The remaining 24 studies reported on the effects of different pharmacological treatments. Outcomes such as functional capacity and psychological functioning of patients were evaluated by few studies. Some evidence supports that 5-hydroxy-tryptophan is more effective than placebo improving neurological symptoms in patients with Friedreich ataxia (FA), olivopontocerebellar atrophy, or cerebellar atrophy. Idebenone is more effective than placebo for halting and reversing the hypertrophic cardiomyopathy associated with FA, but it seems unable to improve neurological semiology. Limited evidence for other therapies was found. No relevant side effects for drugs that shown some degree of effectiveness were reported. Availability of quality studies to evaluate the safety and efficacy of treatments for most DA is scarce. No valid information on the actual value of physical rehabilitation and psychological support as treatments for DA is available. Further investigations with improved trial designs are necessary. © 2009 Movement Disorder Society.</div></front></TEI><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Trujillo Martin, M Mar" sort="Trujillo Martin, M Mar" uniqKey="Trujillo Martin M" first="M. Mar" last="Trujillo-Martin">M. Mar Trujillo-Martin</name></noRegion><name sortKey="Carrillo Fumero, Romen" sort="Carrillo Fumero, Romen" uniqKey="Carrillo Fumero R" first="Romen" last="Carrillo-Fumero">Romen Carrillo-Fumero</name><name sortKey="Monton Alvarez, Fernando" sort="Monton Alvarez, Fernando" uniqKey="Monton Alvarez F" first="Fernando" last="Monton-Alvarez">Fernando Monton-Alvarez</name><name sortKey="Serrano Aguilar, Pedro" sort="Serrano Aguilar, Pedro" uniqKey="Serrano Aguilar P" first="Pedro" last="Serrano-Aguilar">Pedro Serrano-Aguilar</name><name sortKey="Serrano Aguilar, Pedro" sort="Serrano Aguilar, Pedro" uniqKey="Serrano Aguilar P" first="Pedro" last="Serrano-Aguilar">Pedro Serrano-Aguilar</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002519 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002519 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:09-0301981
|texte= Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review
}}
| This area was generated with Dilib version V0.6.23. |  |